A Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Relacorilant
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Relacorilant
Related studies linked through entity extraction aliases.
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas
- Status
- COMPLETED
- Phase
- PHASE3
Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s
- Status
- COMPLETED
- Phase
- PHASE1